NCT05722496

Brief Summary

The goal of this study is to find out the effect of interval versus continous intradialytic training on muscle quality index and functional capacity in Hemodialysis patients. The main question it aims to answer is: Does interval versus continous intradialytic training have an effect on muscle quality index and functional capacity in hemodialysis patients? Patients will be assigned randomly by computerized block randomization into two groups:Group (A): 30 patients will participate in 8 weeks of aerobic exercise in the form of high intensity interval training (HIIT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week).Group (B): 30 patients will participate in 8 weeks of aerobic exercise in the form of moderate intensity continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week) . primary and secondary variables will be measured before starting treatment and after completion (after 2 months )

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2023

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

January 23, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 10, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2023

Completed
Last Updated

September 26, 2023

Status Verified

September 1, 2023

Enrollment Period

8 months

First QC Date

January 23, 2023

Last Update Submit

September 24, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • muscle quality index

    The MQI was quantified using a timed sit-to-stand test, body mass, and leg length to calculate a power index that is expressed in watts (W). The MQI was calculated as follows: QI (Watts) = ((Leg length×0.4) ×Bodymass×gravity×10) ∕ Time taken for (sit to stand 5 times) Body mass will be measured using a digital scale. Leg length will be taken using tape measure to measure the distance (in meters) from the greater trochanter of the femur to the lateral malleolus, measured from standing position . BY using a stopwatch, sit-to-stand time will be calculated as the time to stand from a seated position and return to sitting consecutively five times. The use of arms not allowed during the sit-to-stand test. Acceleration of gravity (9.8 m/s2). After measuring leg length, body mass and time for sit to stand, all these data will be written in the previous equation to calculate muscle quality index and expressed in watts (W).

    2 months

  • six minute walk test

    Six minute walk test (6MWT) to assess physical functional capacity (using stopwatch, colored tape to mark starting line and end line of corridor) Using a stopwatch, assess physical functional capability. The 6MWT will be conducted indoors along a 30 m long, level, straight, enclosed hallway, with the length of the corridor indicated with brightly coloured tape at the beginning and end lines. Subjects will be advised to walk as far as possible from end to end of the corridor without jogging or running, and to cover as much distance as feasible in the 6 minute time limit . This test was performed at the beginning of treatment and at the end of treatment program (8 weeks) to assess functional performance difference.

    2 months

Study Arms (2)

High Intensity Interval Training Group (Group A)

EXPERIMENTAL

Each training session consist of three parts of 30 minutes: * Warm up (5 minutes) free active exercise of the lower extremities, * Training continued with three exercise intervals lasting 3 min each, at an exercise intensity of 85%-95% of HRpeak equalling 15-17 on the Borg scale. Each interval was separated by 4 min of active breaks at an intensity of 60%-70% of HRpeak. * Cool down (5 minutes) free exercise of lower extremities. Training program will last for 8 weeks with frequency 3times / week.

Other: Aerobic pedaling exercise

Moderate intensity continous training group (Group B)

EXPERIMENTAL

Each training session consist of three parts of 30 minutes: * Warm up (5 minutes) free active exercise of the lower extremities, * Training continued with cycling at low-to-moderate exercise intensity of 50%-60% of HRpeak, representing 11-13 on the Borg scale. * Cool down (5 minutes) free exercise of lower extremities. Training program will last for 8 weeks with frequency 3times / week.

Other: Aerobic pedaling exercise

Interventions

aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer by different intensities

High Intensity Interval Training Group (Group A)Moderate intensity continous training group (Group B)

Eligibility Criteria

Age45 Years - 55 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 45- 55 years.
  • Male sex included.
  • Patients with grade 5 chronic renal failure on hemodialysis.
  • Patients are on hemodialysis for 1-3 years.
  • Body mass index (BMI) range from 25-34.9 Kg/m2.
  • They will be medically and psychologically stable.
  • Receiving their physician-prescribed pharmacotherapy regularly.
  • Agree to participate by signing an informed consent form.

You may not qualify if:

  • Inability to comprehend and follow instructions as in dementia or speech problems such as dysphasia.
  • Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis.
  • Acute systemic infection.
  • Presence of malignant disease.
  • Patients with Diabetes Mellitus.
  • Patients with Lupus Nephritis.
  • Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection.
  • Severe obesity (BMI \> 35).
  • Chronic inflammatory orthopedic disorders and rheumatoid arthritis.
  • Patients with muscle injuries or neuromuscular disorders (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of physical therapy, cairo university

Cairo, Dokki, 12611, Egypt

Location

Study Officials

  • hala m ezz eldeen, professor

    department of cardiovascular, respiratory and geriatrics disorders

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
block randomization and envelopes
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be assigned randomly by computerized block randomization into two groups:Group (A): 30 patients aged between 45 - 55 years old will participate in 8 weeks of aerobic exercise in the form of high intensity interval training (HIIT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week). Group (B): 30 patients aged between 45- 55 years old will participate in 8 weeks of aerobic exercise in the form of moderate intensity continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer at department of cardiovascular, respiratory and geriatrics

Study Record Dates

First Submitted

January 23, 2023

First Posted

February 10, 2023

Study Start

January 3, 2023

Primary Completion

September 10, 2023

Study Completion

September 10, 2023

Last Updated

September 26, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

after completion of the study and publication, data will be available for other researchers

Locations